Adagio Therapeutics Inc
(NQ:
ADGI
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Sep 12, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Adagio Therapeutics Inc
< Previous
1
2
3
4
5
6
Next >
Mid-Morning Market Update: Markets Mostly Lower; Producer Prices Rise 0.8% In November
December 14, 2021
Following the market opening Tuesday, the Dow traded up 0.06% to 35,673.60 while the NASDAQ fell 1.08% to 15,247.22. The S&P also fell, dropping 0.57% to 4,642.29. The U.S....
Via
Benzinga
54 Biggest Movers From Yesterday
December 08, 2021
Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 66.7% to close at $4.60 on Tuesday. Siyata Mobile received $1.3 million purchase order for SD7 ruggedized devices and...
Via
Benzinga
60 Biggest Movers From Yesterday
December 07, 2021
Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares jumped 200.4% to close at $15.05 on Monday after the company announced the commencement of a formal process to explore...
Via
Benzinga
36 Stocks Moving In Monday's Mid-Day Session
December 06, 2021
Gainers Del Taco Restaurants, Inc. (NASDAQ: TACO) shares jumped 64.6% to $12.40. Jack In The Box Inc (NASDAQ: JACK) agreed to acquire Del Taco Restaurants for $12.51 per share...
Via
Benzinga
Will Adagio's COVID Antibody Therapy Be Too Late to the Party?
December 04, 2021
It's quite possible.
Via
The Motley Fool
Exposures
COVID-19
Stock Market Rally Hammered On Hawkish Fed, Omicron Fears; Salesforce, Snowflake, DocuSign, Xpeng In Focus: Weekly Review
December 03, 2021
Stocks suffered sharp losses, amid omicron fears and a more-hawkish Fed.
Via
Investor's Business Daily
Topics
Bonds
Economy
Stocks
Exposures
Debt Markets
Fossil Fuels
Interest Rates
Spatial Computing Stocks: 14 Things to Know About Matterport as MTTR Gives Back Some Gains Today
November 30, 2021
Matterport (MTTR) stock is taking a beating on Tuesday as the spatial computing company pulls back from a recent rally of its shares.
Via
InvestorPlace
META ETF: 10 Things to Know About the Roundhill Ball Metaverse ETF
November 30, 2021
Roundhill Ball Metaverse ETF (META) is catching the eyes of investors today as extra interest is placed on Metaverse ETFs.
Via
InvestorPlace
Adagio Continues Its Run As Biotech Stocks Moderna, BioNTech Dive On Omicron Threat
November 30, 2021
Biotech stocks diverged Tuesday with Adagio continuing a run on the potential for its antibody to target Covid's omicron variant.
Via
Investor's Business Daily
35 Stocks Moving In Tuesday's Mid-Day Session
November 30, 2021
Gainers Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) shares jumped 105.9% to $4.53. The FDA approved expanded labeling for Cumberland Pharmaceuticals’ Caldolor, an...
Via
Benzinga
Exposures
Product Safety
ADGI Stock: The Social Media Chatter That Has Adagio Therapeutics Soaring Today
November 30, 2021
Adagio Therapeutics (ADGI) stock is rising higher on Tuesday as investors on social media can't stop talking about the company.
Via
InvestorPlace
Exposures
COVID-19
Mid-Morning Market Update: Markets Mostly Lower; JinkoSolar Issues Weak Sales Forecast
November 30, 2021
Following the market opening Tuesday, the Dow traded down 0.60% to 34,923.74 while the NASDAQ climbed 0.16% to 15,807.66. The S&P also fell, dropping 0.32% to 4,640.44...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
ADGI Stock Soars as Analysts Lock On to Its Omicron-Fighting Potential
November 29, 2021
Shares of ADGI stock are soaring higher by 80% after the company stated that its ADG-20 antibody is effective against the omicron variant.
Via
InvestorPlace
Exposures
COVID-19
Mid-Afternoon Market Update: Dow Jumps 300 Points; Krystal Biotech Shares Spike Higher
November 29, 2021
Toward the end of trading Monday, the Dow traded up 0.87% to 35,204.42 while the NASDAQ climbed 1.96% to 15,795.08. The S&P also rose, gaining 1.55% to 4,665.67. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
50 Biggest Movers From Yesterday
November 30, 2021
Gainers Krystal Biotech, Inc. (NASDAQ: KRYS) shares surged 121.7% to close at $88.24 on Monday after the company announced positive topline results from the GEM-3 Phase 3 trial...
Via
Benzinga
Adagio shares soar on antibody potential against new COVID variant omicron
November 29, 2021
Stifel analyst Stephen Willey believes vaccines alone are unlikely to sufficiently address the COVID-19 pandemic.
Via
Talk Markets
Exposures
COVID-19
3 Pharma Stocks Morgan Stanley Says Will Be Omicron Variant Beneficiaries
November 29, 2021
The news of a new variant of the coronavirus Friday sent financial markets into a tailspin. The adversity could present an opportunity for a h...
Via
Benzinga
Exposures
COVID-19
Mid-Day Market Update: Crude Oil Rises 4%; Fennec Pharmaceuticals Shares Slide
November 29, 2021
Midway through trading Monday, the Dow traded up 0.30% to 35,005.10 while the NASDAQ climbed 1.39% to 15,707.48. The S&P also rose, gaining 0.97% to 4,639.11. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
33 Stocks Moving In Monday's Mid-Day Session
November 29, 2021
Gainers Krystal Biotech, Inc. (NASDAQ: KRYS) shares jumped 116.4% to $86.13 after the company announced positive topline results from the GEM-3 Phase 3 trial of investigational...
Via
Benzinga
Vaccine Stocks Ask The Unthinkable: What Happens If Today's Covid Shots Fail?
November 29, 2021
Smaller companies are working on next-generation approaches to Covid treatment.
Via
Investor's Business Daily
Mid-Morning Market Update: Markets Open Higher; Li Auto Sales Top Views
November 29, 2021
Following the market opening Monday, the Dow traded up 0.22% to 34,977.01 while the NASDAQ climbed 1.53% to 15,727.94. The S&P also rose, gaining 0.92% to 4,637.03. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2021
November 29, 2021
Upgrades According to Odeon Capital, the prior rating for Wells Fargo & Co (NYSE:
Via
Benzinga
Adagio Says Its COVID-19 Antibody Likely To Retain Activity Against Omicron Variant
November 29, 2021
Adagio Therapeutics Inc (NASDAQ: ADGI) says that its COVID-19 monoclonal antibody, ADG20, is likely to retain activity against Omicron, as observed in in vitro models...
Via
Benzinga
Exposures
COVID-19
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
November 29, 2021
I hope you got your rest out over the holiday weekend because we're starting off Monday with the biggest pre-market stock movers!
Via
InvestorPlace
Exposures
COVID-19
56 Biggest Movers From Friday
November 29, 2021
Gainers iSpecimen Inc. (NASDAQ: ISPC) climbed 71.7% to settle at $17.51 on Friday. The company recently announced it has been contracted to support new advanced research on...
Via
Benzinga
Mid-Day Market Update: Dow Tumbles Over 900 Points; Crude Oil Down 12%
November 26, 2021
Midway through trading Friday, the Dow traded down 2.60% to 34,873.25 while the NASDAQ fell 1.84% to 15,553.65 after a new COVID-19 variant was detected in South Africa....
Via
Benzinga
Topics
Stocks
Exposures
COVID-19
Fossil Fuels
US Equities
48 Stocks Moving In Friday's Mid-Day Session
November 26, 2021
Gainers Allied Healthcare Products, Inc. (NASDAQ: AHPI) shares jumped 68% to $9.04. Shares of mask and protective apparel companies, including Allied Healthcare Products, traded...
Via
Benzinga
Mid-Morning Market Update: Markets Open Lower; Europe's Regulator Backs Pfizer's COVID-19 Vaccine For Kids Aged 5-11 Years
November 26, 2021
Following the market opening Friday, the Dow traded down 2.57% to 34,885.52 while the NASDAQ fell 1.55% to 15,599.06 after a new COVID-19 variant was detected in South Africa. The...
Via
Benzinga
Topics
Stocks
Exposures
COVID-19
US Equities
64 Stocks Moving In Friday's Mid-Day Session
November 05, 2021
Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 198.4% to $14.92. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the middle of the...
Via
Benzinga
92 Biggest Movers From Friday
November 08, 2021
Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares jumped 99.8% to close at $9.99 on Friday. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.